Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $111.86 | $24.52 | 356.24% | 211.06x | 191.74x | 14.19x | 17.13x | 1.63x | $106.92M | 0.91% | $705.78M | 6.70 | $11.99B | 1,528.40 | ||
| LQDA | LIQUIDIA CORP | $88.05 | $17.04 | 416.58% | 366.88x | 26.50x | 26.90x | 72.11x | 1.78x | $41.15M | 0.53% | $108.58M | 1.23 | $7.79B | 145.39 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $221.20 | $94.52 | 134.02% | 36.26x | 30.53x | 6.15x | 21.86x | 1.10x | $793.95M | 2.69% | $1.35B | 10.14 | $30.88B | 26.18 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.23 | $8.30 | 216.12% | 124.90x | 163.02x | 7.38x | 14.95x | 1.16x | $39.15M | 1.14% | $220.58M | 1.69 | $3.38B | 74.38 | ||
| ADMA | ADMA BIOLOGICS INC | $9.91 | $8.73 | 13.50% | 13.76x | 11.81x | 4.41x | 5.43x | 0.62x | $116.47M | 5.15% | $408.21M | 1.79 | $2.28B | 9.79 | ||
| ASND | ASCENDIS PHARMA A | $254.57 | $76.17 | 234.20% | 26.98x | 17.50x | 15.52x | 27.54x | 2.81x | $52.94M | 0.33% | $574.09M | 9.24 | $16.19B | 173.64 | ||
| KRYS | KRYSTAL BIOTECH INC | $327.05 | $86.28 | 279.06% | 39.55x | 42.89x | 21.92x | 7.12x | 2.33x | $257.78M | 2.67% | $1.36B | 46.03 | $9.26B | 39.70 | ||
| HALO | HALOZYME THERAPEUTICS INC | $102.62 | $70.81 | 44.92% | 28.83x | 12.36x | 7.23x | 81.14x | 0.62x | $806.22M | 6.70% | $143.54M | 1.22 | $13.63B | 18.97 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $77.80 | $16.41 | 374.14% | 72.71x | 61.80x | 7.18x | 9.28x | 2.25x | $182.84M | 3.03% | $654.15M | 8.43 | $5.90B | 49.21 | ||
| RPRX | ROYALTY PHARMA PLC | $57.79 | $38.48 | 50.19% | 30.74x | 10.77x | 10.14x | 3.40x | 0.64x | $2.92B | 11.37% | $9.79B | 21.99 | $41.38B | 35.18 | ||
| VCEL | VERICEL CORP | $44.35 | $8.88 | 399.34% | 92.40x | 91.99x | 7.40x | 6.14x | 2.19x | $61.66M | 2.72% | $370.04M | 7.25 | $2.24B | 50.81 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.08 | $2.24 | 37.79% | 15.40x | 13.32x | 1.89x | 2.95x | 0.80x | $5.67M | 2.34% | $82.53M | 1.04 | $179.30M | 9.59 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.34 | $9.43 | 20.20% | 11.94x | 10.95x | 4.93x | 3.09x | 0.77x | $82.01M | 12.22% | $217.65M | 3.68 | $529.59M | 6.85 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $69.55 | $21.21 | 227.84% | 183.03x | 18.72x | 3.95x | 2.13x | 1.15x | $738.18M | 5.49% | $6.32B | 32.68 | $16.78B | 43.49 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $247.98 | $194.62 | 27.42% | 16.25x | 9.61x | 3.41x | 3.35x | 0.67x | $1.62B | 10.33% | $4.80B | 75.98 | $18.87B | 11.68 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $288.75 | $93.30 | 209.47% | 28.67x | 31.25x | 19.94x | 5.95x | 2.15x | $130.62M | 2.25% | $967.52M | 48.22 | $5.88B | 21.08 | ||
| MDXG | MIMEDX GROUP INC | $4.32 | $1.11 | 290.70% | 108.00x | -38.50x | 1.80x | 2.92x | 1.52x | $44.50M | 6.97% | $216.00M | 1.46 | $511.05M | 22.41 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.23 | $8.54 | -85.59% | 4.56x | -4.16x | 1.15x | 1.35x | 0.05x | $7.24M | 10.24% | $52.93M | 0.92 | $17.56M | 1.13 | ||
| TGTX | TG THERAPEUTICS INC | $49.90 | $23.83 | 109.40% | 16.20x | 35.41x | 8.85x | 12.64x | 1.90x | $17.39M | 0.25% | $604.08M | 4.26 | $7.91B | 56.80 | ||
| TECH | BIO-TECHNE CORP | $72.15 | $15.92 | 353.07% | 101.62x | 34.58x | 9.32x | 5.42x | 1.86x | $269.60M | 2.39% | $2.09B | 13.34 | $11.38B | 44.44 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $797.00 | $414.18 | 92.43% | 19.00x | 17.07x | 5.27x | 2.59x | 1.25x | $3.76B | 4.59% | $31.71B | 308.48 | $82.31B | 14.31 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $529.65 | $156.84 | 237.71% | 30.56x | 27.39x | 10.68x | 6.63x | 2.42x | $3.80B | 2.83% | $20.25B | 79.81 | $130.08B | 23.64 | ||
| UTHR | UNITED THERAPEUTICS CORP | $515.50 | $223.17 | 130.99% | 17.05x | 18.84x | 6.96x | 19.73x | 2.30x | $1.09B | 4.98% | $6.40B | 150.24 | $124.49B | 74.26 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.52 | $32.74 | 20.71% | 12.59x | 10.41x | 2.39x | 2.30x | 0.74x | $354.90M | 15.50% | $999.24M | 17.25 | $1.91B | 6.81 | ||
| EXEL | EXELIXIS INC | $51.33 | $28.38 | 80.88% | 15.60x | 15.95x | 5.29x | 6.90x | 1.38x | $1.17B | 9.11% | $1.84B | 7.35 | $12.60B | 11.59 | ||
| INCY | INCYTE CORP | $121.07 | $60.07 | 101.55% | 14.91x | 15.93x | 4.17x | 3.87x | 1.99x | $1.92B | 7.92% | $6.34B | 31.66 | $20.59B | 9.96 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.